🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.100
-0.005 (-0.45%)
At close: Nov 18, 2026, 4:00 PM EST
1.100
0.00 (0.00%)
After-hours: Nov 18, 2026, 7:30 PM EST

Company Description

OKYO Pharma Limited, a clinical-stage ophthalmology company, develops therapies for corneal and anterior diseases in the United Kingdom.

Its lead clinical product candidate is urcosimod, which is in Phase 2 clinical trials for the treatment of dry eye disease and neuropathic corneal pain.

The company is also developing OK-201 for the treatment of acute and chronic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

OKYO Pharma Limited
OKYO Pharma logo
CountryUnited Kingdom
Founded2007
IPO DateMay 17, 2022
IndustryBiotechnology
SectorHealthcare
Employees5
CEORobert Dempsey

Contact Details

Address:
35a Albemarle St, Floor 2
London, W1S 4JE
United Kingdom
Phone44 20 7495 2379
Websiteokyopharma.com

Stock Details

Ticker SymbolOKYO
ExchangeNASDAQ
Fiscal YearApril - March
Reporting CurrencyUSD
IPO Price$4.00
CIK Code1849296
CUSIP NumberG6724L116
ISIN NumberGG00BMFG5F62
SIC Code2836

Key Executives

NamePosition
Robert J. Dempsey M.B.A.Chief Executive Officer and Executive Director
Keeren ShahChief Financial Officer
Dr. Rajkumar Patil Ph.D.Chief Scientific Officer
Dr. Gary S. Jacob Ph.D.Chief Development Officer and Director
Dr. Flavio Mantelli M.D., Ph.D.Chief Medical Officer
Michael Paul BeckFounder

Latest SEC Filings

DateTypeTitle
Nov 12, 20266-KReport of foreign issuer
Nov 5, 20266-KReport of foreign issuer
Oct 6, 20266-KReport of foreign issuer
Sep 29, 20266-KReport of foreign issuer
Sep 9, 20266-KReport of foreign issuer
Sep 8, 20266-KReport of foreign issuer
Aug 7, 202620-F/AFiling
Jul 28, 20266-KReport of foreign issuer
Jul 27, 20266-KReport of foreign issuer
Jul 23, 20266-KReport of foreign issuer
Investor Relations Documents
Annual and quarterly reports, earnings releases, and presentation slides